Stryker’s Early 2022 Growth Constrained by Supply Pressures

Stryker reported 1Q22 orthopedic sales of $2,197 million, +6.2% compared to 1Q21.

The company benefitted from procedure volume recovery across orthopedics as well as new product introductions, like the Insignia hip stem. The ongoing integration of Wright Medical continued its progress with both the foot/ankle and shoulder businesses turning...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us